Search
Diethylamino hydroxybenzoyl hexyl benzoate
go.drugbank.com/drugs/DB11269ApprovedIt has a chemical structure similar to the classical benxophoenone drug class, and displays good photostability [A33171]. … It is used in concentrations up to 10% in sunscreen products, either alone or in combination with other UV absorbers [F107].
Equine Botulinum Neurotoxin E Immune FAB2
go.drugbank.com/drugs/DB13897ApprovedEquine Botulinum Neurotoxin E Immune FAB2 is composed of a mixture of immune globulin fragments purified from plasma of horses that were previously immunized with botulinum toxin serotype E. … It is intravenously administered for the treatment of symptomatic botulism following documented or suspected exposure to botulinum neurotoxin serotypes E in adults and pediatric patients.
Synonyms: Botulinum Neurotoxin E immune FAB2 (equine), BOTULINUM NEUROTOXIN E IMMUNE FAB2, EQUINEEquine Botulinum Neurotoxin C Immune FAB2
go.drugbank.com/drugs/DB13898ApprovedIt is intravenously administered for the treatment of symptomatic botulism following documented or suspected exposure to botulinum neurotoxin serotypes C in adults and pediatric patients.
Iobenguane
go.drugbank.com/drugs/DB06704ApprovedInvestigationalIodine 123 is a cyclotron-produced radionuclide that decays to Te 123 by electron capture. Images are produced by a I123 MIBG scintigraphy. FDA approved on September 19, 2008.
Products: IOBENGUANO [131 I] GE HEALTHCARE TGastric intrinsic factor
go.drugbank.com/drugs/DB09349ApprovedHowever, it is currently in the marketed (but unapproved) product Hematogen in combination with cyanocobalamin (synthetic Vitamin B12), ferrous fumarate, and ascorbic acid for the treatment of anemias
Clonixin
go.drugbank.com/drugs/DB09218InvestigationalClonixin is a non-steroidal anti-inflammatory drug.
Mixtures: CLONIXINATO / CICLOBENZAPRINA 125MG/5MGDextropropoxyphene
go.drugbank.com/drugs/DB00647ApprovedIllicitWithdrawnIt is used in the symptomatic treatment of mild pain. It displays antitussive and local anaesthetic actions.
Etizolam
go.drugbank.com/drugs/DB09166InvestigationalIt is not approved for use by FDA in the US; however it remains unscheduled in several states and is legal for research purposes. … It is an agonist at GABA-A receptors and possesses amnesic, anxiolytic, anticonvulsant, hypnotic, sedative and skeletal muscle relaxant properties.
International brands: E1Eslicarbazepine acetate
go.drugbank.com/drugs/DB09119ApprovedInvestigationalEslicarbazepine's mechanism of action is not well understood, but it is known that it does exert anticonvulsant activity by inhibiting repeated neuronal firing and stabilizing the inactivated state of … It is recommended that patients taking eslicarbazepine acetate be monitored for suicidality.
Products: Eslibon 200 mg-Tabletten, Eslibon 400 mg-TablettenMetergoline
go.drugbank.com/drugs/DB13520ApprovedMetergoline is an antagonist at various 5-HT receptor subtypes at a relatively low concentration and agonist at dopamine receptors.